News Website

Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study - Medical Dialogues

Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study Medical Dialogues

Published: April 25, 2025, 3 p.m.

Read Full Article

Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data - Frontiers

Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data Frontiers

Published: April 25, 2025, 10:08 a.m.

Read Full Article

AI diagnoses endometrial cancer with high accuracy - Lab + Life Scientist

AI diagnoses endometrial cancer with high accuracy Lab + Life Scientist

Published: April 23, 2025, 1:24 a.m.

Read Full Article

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer OncLive

Published: April 21, 2025, 1:17 p.m.

Read Full Article

Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor

Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer Oncology Nurse Advisor

Published: April 21, 2025, 4 a.m.

Read Full Article

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer OncLive

Published: April 18, 2025, 3:54 p.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.

Read Full Article

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery - Cureus

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery Cureus

Published: April 17, 2025, 11:08 p.m.

Read Full Article

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.

Read Full Article

Latest Articles

Sex Hormones Increase Endometrial Cancer Risk in Postmenopausal Women: Study - Medical Dialogues

Evaluation of Pyroptosis-Associated Genes in Endometrial Cancer Utilizing a 101-Combination Machine Learning Framework and Multi-Omics Data - Frontiers

AI diagnoses endometrial cancer with high accuracy - Lab + Life Scientist

Impact of Combination Therapy: Evaluating the Influence of Lenvatinib and Pembrolizumab in Relapsed Endometrial Cancer - OncLive

Cadonilimab-Lenvatinib Combo Exhibits Activity in Advanced Endometrial Cancer - Oncology Nurse Advisor

Dostarlimab/Chemo Earns Expanded Canadian Approval in Primary Advanced, First Recurrent Endometrial Cancer - OncLive

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Impact of Positive Peritoneal Cytology on Prognosis in Stage IA Endometrial Cancer: A Retrospective Cohort Study in the Era of Minimally Invasive Surgery - Cureus

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Subscribe to Our Newsletter